Dana Rizk, MD - Unlocking the Potential of B-Cell Modulation Therapies in IgA Nephropathy

Visit https://www.peervoice.com/NEX860 to view the entire programme with slides. After completing “Dana Rizk, MD - Unlocking the Potential of B-Cell Modulation Therapies in IgA Nephropathy”, participants will be able to: Outline the role of Gd-IgA1 and specific immune-mediated mechanisms in the pathophysiology of IgA nephropathy (IgAN); Summarize the relationship between key predictors of long-term outcome and their role in assessing risk of progression in patients with IgAN; Describe the role of different immune-specific targets in IgAN; and Evaluate clinical data regarding therapies targeting immune-specific mediators of disease in patients with IgAN.

Om Podcasten

PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.